Incyte (INCY) Operating Expenses (2010 - 2026)

Incyte (INCY) has 17 years of Operating Expenses data on file, last reported at $971.6 million in Q1 2026.

• For the quarter ending Q1 2026, Operating Expenses rose 14.61% year-over-year to $971.6 million; the trailing twelve-month figure through Mar 2026 stood at $3.8 billion (down 11.52% YoY), and the FY2025 full-year result was $3.6 billion, down 13.24% from the prior year.
• Operating Expenses for Q1 2026 stood at $971.6 million, down from $1.2 billion in the prior quarter.
• Across five years, Operating Expenses topped out at $1.5 billion in Q2 2024 and bottomed at $616.7 million in Q1 2022.
• The 5-year median for Operating Expenses is $826.1 million (2023), against an average of $862.8 million.
• The widest annual swing landed in 2024, when Operating Expenses soared 100.03%; it then tumbled 54.98% in 2025.
• A 5-year view of Operating Expenses shows it stood at $856.6 million in 2022, then declined by 3.56% to $826.1 million in 2023, then advanced by 6.19% to $877.2 million in 2024, then surged by 33.49% to $1.2 billion in 2025, then declined by 17.03% to $971.6 million in 2026.
• The last three Operating Expenses figures came in at $971.6 million (Q1 2026), $1.2 billion (Q4 2025), and $922.5 million (Q3 2025), per Business Quant data.

Peer Comparison